Professor Zhengming Chen
- Assessing effects of environmental exposures using novel personal exposure metrics on risk factors and major diseases (MRC PHRU)
- Assessment of host and pathogen determinants of infection-related cancer and other chronic diseases in Chinese adults (MRC PHRU)
- Bone mineral density and osteoporosis: patterns, determinants and their relationships with cardiometabolic disorders in Chinese adults
- Burden and risk factors of infectious complications among Chinese adults with diabetes (MRC PHRU)
- Burden and risk factors of infectious complications among Chinese adults with diabetes
- Causal relevance of reproductive factors for major chronic diseases in Chinese women (MRC PHRU)
- Development of cardiovascular risk prediction model for Chinese adults
- Epidemiology of autoimmune disease in Chinese adults
- Female reproductive history and risks of cancer and other diseases in a prospective cohort study of 300,000 Chinese women
- Medical Research Council Population Health Research Unit (MRC PHRU)
- Patterns and risk factors of arthritis, fractures and other musculoskeletal disorders in 0.5 million Chinese adults
- Phenome-wide association studies of functional genetic variants to validate drug targets (MRC PHRU)
- Phenome-wide association studies of functional genetic variants to identify and validate drug targets
- Physical activity and risk of non-vascular chronic diseases in Chinese men and women
Professor of Epidemiology and Director of China Programmes
- Clinical Trial Service Unit and Epidemiological Studies Unit
Professor Zhengming Chen qualified in medicine at Shanghai Medical University in 1983 (now Fudan University), and gained his DPhil in Epidemiology at the University of Oxford in 1993. He was appointed as Professor of Epidemiology by the University of Oxford in 2006. He is now the Director of the China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) and co-executive director of the China Oxford Centre for International Health Research. His main researches focus on the environmental and genetic causes of chronic disease, evidence-based medicine and evaluation of widely practicable treatments for chronic diseases (such as IHD, stroke and cancer) as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has led several large randomised trials in heart disease (eg, COMMIT/CCS-2), stroke (eg, CAST) and cancer and 3 cohort studies involving >750,000 individuals. Since 2003 he has been the lead principal investigator in the UK for the China Kadoorie Biobank (CKB) prospective study of 0.5 million adults. He leads a research team in Oxford which is responsible for study design and development of procedures and IT systems for the CKB, and for central data management, curation and detailed analyses. He is an honorary professor of Peking Union Medical College and Fudan University in China.
Genomic Analyses from Non-invasive Prenatal Testing Reveal Genetic Associations, Patterns of Viral Infections, and Chinese Population History.
Liu S. et al, (2018), Cell, 175, 347 - 359.e14
Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people.
Pang Y. et al, (2018), J epidemiol community health, 72, 919 - 925
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.
Pang Y. et al, (2018), Hepatology, 68, 1308 - 1318
Solid Fuel Use and Risks of Respiratory Diseases: A Cohort Study of 280,000 Chinese Never-Smokers.
Chan KH. et al, (2018), Am j respir crit care med
Association between tea drinking and stroke in adults in Zhejiang province: A Prospective study
Wang H. et al, (2018), Chinese journal of endemiology, 39, 1200 - 1205